Published in Osteoarthritis Cartilage on April 01, 2004
Efficacy Study of Condrosulf in the Treatment of Symptomatic OA of the Hand | NCT00291499
Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib. Ann Rheum Dis (2015) 1.68
Joint space narrowing and Kellgren-Lawrence progression in knee osteoarthritis: an analytic literature synthesis. Osteoarthritis Cartilage (2008) 1.49
Update on guidelines for the treatment of chronic musculoskeletal pain. Clin Rheumatol (2006) 1.34
Responsiveness to change and reliability of measurement of radiographic joint space width in osteoarthritis of the knee: a systematic review. Osteoarthritis Cartilage (2011) 1.24
Most recent developments in strategies to reduce the progression of structural changes in osteoarthritis: today and tomorrow. Arthritis Res Ther (2006) 1.11
Effect of glucosamine or chondroitin sulfate on the osteoarthritis progression: a meta-analysis. Rheumatol Int (2009) 1.11
Immunomodulatory and anti-inflammatory effects of chondroitin sulphate. J Cell Mol Med (2009) 1.02
Effects of Glucosamine and Chondroitin Sulfate on Cartilage Metabolism in OA: Outlook on Other Nutrient Partners Especially Omega-3 Fatty Acids. Int J Rheumatol (2011) 0.95
Chondroitin for osteoarthritis. Cochrane Database Syst Rev (2015) 0.94
Optimization of scAAVIL-1ra In Vitro and In Vivo to Deliver High Levels of Therapeutic Protein for Treatment of Osteoarthritis. Mol Ther Nucleic Acids (2013) 0.85
Chondroitin sulphate: a focus on osteoarthritis. Glycoconj J (2016) 0.81
Effect of 12 months treatment with chondroitin sulfate on cartilage volume in knee osteoarthritis patients: a randomized, double-blind, placebo-controlled pilot study using MRI. Clin Rheumatol (2012) 0.81
The effect of doxycycline on canine hip osteoarthritis: design of a 6-months clinical trial. J Vet Sci (2009) 0.79
Quantitative cartilage volume measurement using MRI: comparison of different evaluation techniques. Eur Radiol (2005) 0.78
Effects of chondroitin sulfate and glucosamine in adult patients with Kaschin-Beck disease. Clin Rheumatol (2010) 0.76
Comparative efficacy and safety study of two chondroitin sulfate preparations from different origin (avian and bovine) in symptomatic osteoarthritis of the knee. Open Rheumatol J (2013) 0.76
Chondroitin sulfate efficacy versus celecoxib on knee osteoarthritis structural changes using magnetic resonance imaging: a 2-year multicentre exploratory study. Arthritis Res Ther (2016) 0.75
Dietary supplements as disease-modifying treatments in osteoarthritis: a critical appraisal. P T (2014) 0.75
Osteoarthritis of the knee. BMJ Clin Evid (2007) 0.75
Effect of chondroitin sulfate on soluble biomarkers of osteoarthritis: a method to analyze and interpret the results from an open-label trial in unilateral knee osteoarthritis patients. BMC Musculoskelet Disord (2016) 0.75
Glucosamine and chondroitin for the treatment of osteoarthritis. World J Orthop (2017) 0.75
Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer. J Clin Oncol (2010) 3.27
Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registry. Arthritis Rheum (2010) 2.68
Therapeutic administration of 131I for differentiated thyroid cancer: radiation dose to ovaries and outcome of pregnancies. J Nucl Med (2008) 2.47
Systematic review and meta-analysis of circulatory disease from exposure to low-level ionizing radiation and estimates of potential population mortality risks. Environ Health Perspect (2012) 2.42
Long-term cardiovascular mortality after radiotherapy for breast cancer. J Am Coll Cardiol (2011) 2.14
DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment. Arthritis Res Ther (2005) 1.96
Measurement of radiographic joint space width in the tibiofemoral compartment of the osteoarthritic knee: comparison of standing anteroposterior and Lyon schuss views. Arthritis Rheum (2003) 1.93
Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial. Ann Rheum Dis (2007) 1.83
Which is the best radiographic protocol for a clinical trial of a structure modifying drug in patients with knee osteoarthritis? J Rheumatol (2002) 1.73
Cross-sectional association of 10 molecular markers of bone, cartilage, and synovium with disease activity and radiological joint damage in patients with hip osteoarthritis: the ECHODIAH cohort. J Rheumatol (2005) 1.69
Pooled analysis of two case-control studies in New Caledonia and French Polynesia of body mass index and differentiated thyroid cancer: the importance of body surface area. Thyroid (2010) 1.65
Chondroitins 4 and 6 sulfate in osteoarthritis of the knee: a randomized, controlled trial. Arthritis Rheum (2005) 1.63
Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA-positive connective tissue diseases. Arthritis Rheum (2004) 1.59
Selection of knee radiographs for trials of structure-modifying drugs in patients with knee osteoarthritis: a prospective, longitudinal study of Lyon Schuss knee radiographs with the definition of adequate alignment of the medial tibial plateau. Arthritis Rheum (2005) 1.58
Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer. J Clin Oncol (2006) 1.56
Exploring the symbiotic pangenome of the nitrogen-fixing bacterium Sinorhizobium meliloti. BMC Genomics (2011) 1.55
Proteomic mass spectra classification using decision tree based ensemble methods. Bioinformatics (2005) 1.52
Immature dendritic cell transdifferentiation into osteoclasts: a novel pathway sustained by the rheumatoid arthritis microenvironment. Blood (2004) 1.50
Incidence rates of thyroid cancer and myeloid leukaemia in French Polynesia. Int J Cancer (2011) 1.39
Menstrual and reproductive factors in the risk of differentiated thyroid carcinoma in native women in French Polynesia: a population-based case-control study. Am J Epidemiol (2007) 1.39
Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: a case-control study by the Société Française d'Oncologie Pédiatrique. J Clin Oncol (2003) 1.36
Malignant breast tumors after radiotherapy for a first cancer during childhood. J Clin Oncol (2005) 1.28
Radiation dose and risk of soft tissue and bone sarcoma after breast cancer treatment. Breast Cancer Res Treat (2005) 1.25
Alkaptonuria, ochronosis, and ochronotic arthropathy. Semin Arthritis Rheum (2004) 1.24
Frequency distribution of second solid cancer locations in relation to the irradiated volume among 115 patients treated for childhood cancer. Int J Radiat Oncol Biol Phys (2009) 1.22
Interleukin-6: An osteotropic factor influencing bone formation? Bone (2005) 1.17
Long-term risk of second malignant neoplasms after neuroblastoma in childhood: role of treatment. Int J Cancer (2003) 1.17
Comment on "dose-responses from multi-model inference for the non-cancer disease mortality of atomic bomb survivors" (Radiat. Environ. Biophys (2012) 51:165-178) by Schöllnberger et al. Radiat Environ Biophys (2013) 1.16
Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial). Clin Cancer Res (2008) 1.15
Anthropometric factors in differentiated thyroid cancer in French Polynesia: a case-control study. Cancer Causes Control (2008) 1.14
Preclinical characterization of DEKAVIL (F8-IL10), a novel clinical-stage immunocytokine which inhibits the progression of collagen-induced arthritis. Arthritis Res Ther (2009) 1.12
Evaluation of anti-oxidant treatments in an in vitro model of alkaptonuric ochronosis. Rheumatology (Oxford) (2010) 1.11
Reactivity to superficial and deep stimuli in patients with chronic musculoskeletal pain. Pain (2002) 1.11
Biomarker discovery for inflammatory bowel disease, using proteomic serum profiling. Biochem Pharmacol (2006) 1.10
Relationship between the brain radiation dose for the treatment of childhood cancer and the risk of long-term cerebrovascular mortality. Brain (2011) 1.10
Germ-line DNA polymorphisms and susceptibility to differentiated thyroid cancer. Lancet Oncol (2009) 1.09
Biochemical investigation of the effects of human platelet releasates on human articular chondrocytes. J Cell Biochem (2009) 1.09
Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach. Arthritis Rheum (2005) 1.08
Evaluation of antioxidant drugs for the treatment of ochronotic alkaptonuria in an in vitro human cell model. J Cell Physiol (2010) 1.06
Challenges for biomarker discovery in body fluids using SELDI-TOF-MS. J Biomed Biotechnol (2009) 1.05
Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: attrition and long-term evolution of disease activity. Arthritis Res Ther (2006) 1.05
Factors predicting patient satisfaction 2 years after total knee arthroplasty for osteoarthritis. Joint Bone Spine (2010) 1.04
A pooled analysis of thyroid cancer incidence following radiotherapy for childhood cancer. Radiat Res (2012) 1.03
Evidence for synovitis in active polymyalgia rheumatica: sonographic study in a large series of patients. J Rheumatol (2002) 1.02
A "new" technique for the diagnosis of chondrocalcinosis of the knee: sensitivity and specificity of high-frequency ultrasonography. Ann Rheum Dis (2007) 1.02
Monomeric calgranulins measured by SELDI-TOF mass spectrometry and calprotectin measured by ELISA as biomarkers in arthritis. Clin Chem (2008) 1.02
Radiation dose, chemotherapy and risk of soft tissue sarcoma after solid tumours during childhood. Int J Cancer (2004) 1.01
A 2-year randomised, double-blind, placebo-controlled, multicentre study of oral selective iNOS inhibitor, cindunistat (SD-6010), in patients with symptomatic osteoarthritis of the knee. Ann Rheum Dis (2012) 1.01
Comparison of second- and third-generation anti-cyclic citrullinated peptide antibodies assays for detecting rheumatoid arthritis. Clin Chim Acta (2007) 1.00
Ionizing radiation biomarkers for potential use in epidemiological studies. Mutat Res (2012) 0.99
A proteomic study on human osteoblastic cells proliferation and differentiation. Proteomics (2006) 0.98
Long-term mortality from second malignant neoplasms in 5-year survivors of solid childhood tumors: temporal pattern of risk according to type of treatment. Cancer Epidemiol Biomarkers Prev (2010) 0.98
The DivJ, CbrA and PleC system controls DivK phosphorylation and symbiosis in Sinorhizobium meliloti. Mol Microbiol (2013) 0.97
Genetic epidemiology of neuroblastoma: a study of 426 cases at the Institut Gustave-Roussy in France. Pediatr Blood Cancer (2004) 0.97
A critical appraisal of guidelines for the management of knee osteoarthritis using Appraisal of Guidelines Research and Evaluation criteria. Arthritis Res Ther (2007) 0.97
Management recommendations for knee osteoarthritis: how usable are they? Joint Bone Spine (2010) 0.96
Proteomics for prediction and characterization of response to infliximab in Crohn's disease: a pilot study. Clin Biochem (2008) 0.95
Osteoarthritis of the knee at 3.0 T: comparison of a quantitative and a semi-quantitative score for the assessment of the extent of cartilage lesion and bone marrow edema pattern in a 24-month longitudinal study. Skeletal Radiol (2011) 0.94
Efficacy of rituximab in systemic manifestations of primary Sjogren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry. Ann Rheum Dis (2012) 0.93
Linear scleroderma associated with progressive brain atrophy. Brain Dev (2003) 0.93
Clinical presentation of osteoarthritis in general practice: determinants of pain in Italian patients in the AMICA study. Semin Arthritis Rheum (2005) 0.92
Dietary iodine and thyroid cancer risk in French Polynesia: a case-control study. Thyroid (2012) 0.92
Early effect of hyaluronic acid intra-articular injections on serum and urine biomarkers in patients with knee osteoarthritis: An open-label observational prospective study. J Orthop Res (2011) 0.92
The risk of multiple primary breast and thyroid carcinomas. Cancer (2003) 0.91
Reproducibility and sensitivity to change of various methods to measure joint space width in osteoarthritis of the hip: a double reading of three different radiographic views taken with a three-year interval. Arthritis Res Ther (2005) 0.91
Clinical response to intra-articular injections of hylan G-F 20 in symptomatic hip osteoarthritis: the OMERACT-OARSI criteria applied to the results of a pilot study. Joint Bone Spine (2006) 0.90
Subcutaneous panniculitis-like T-cell lymphoma misdiagnosed as lupus erythematosus panniculitis. Clin Rheumatol (2006) 0.90
Effects of high dose methylprednisolone pulse therapy on bone mass and biochemical markers of bone metabolism in patients with active rheumatoid arthritis: a 12-month randomized prospective controlled study. J Rheumatol (2004) 0.90
Family history of thyroid cancer and the risk of differentiated thyroid cancer in French polynesia. Thyroid (2010) 0.89
Radiation dose and long term risk of cardiac pathology following radiotherapy and anthracyclin for a childhood cancer. Radiother Oncol (2006) 0.89
A composite index for total hip arthroplasty in patients with hip osteoarthritis. J Rheumatol (2002) 0.88
Expression of cell cycle biomarkers and telomere length in papillary thyroid carcinoma: a comparative study between radiation-associated and spontaneous cancers. Am J Clin Oncol (2009) 0.88
Discovery and biochemical characterisation of four novel biomarkers for osteoarthritis. Ann Rheum Dis (2011) 0.88
Bone morphogenetic protein-2 stimulates chondrogenic expression in human nasal chondrocytes expanded in vitro. Growth Factors (2008) 0.88
Factors predicting long-term efficacy of Hylan GF-20 viscosupplementation in knee osteoarthritis. Joint Bone Spine (2003) 0.87
Clinical and radiographic distribution of structural damage in erosive and nonerosive hand osteoarthritis. Arthritis Care Res (Hoboken) (2012) 0.87
Do physicians treat symptomatic osteoarthritis patients properly? Results of the AMICA experience. Semin Arthritis Rheum (2005) 0.87
Gene expression signature discriminates sporadic from post-radiotherapy-induced thyroid tumors. Endocr Relat Cancer (2011) 0.87
Ultrasonographic study of Achilles tendon and plantar fascia in chondrocalcinosis. J Rheumatol (2004) 0.87
Raloxifene-induced myeloma cell apoptosis: a study of nuclear factor-kappaB inhibition and gene expression signature. Mol Pharmacol (2006) 0.87
Spa therapy: can be a valid option for treating knee osteoarthritis? Int J Biometeorol (2014) 0.87
Therapeutic effect of spa therapy and short wave therapy in knee osteoarthritis: a randomized, single blind, controlled trial. Rheumatol Int (2006) 0.87
The apoptosis of osteoblasts and osteocytes in femoral head osteonecrosis: its specificity and its distribution. Clin Rheumatol (2014) 0.86
Osteogenic growth peptide effects on primary human osteoblast cultures: potential relevance for the treatment of glucocorticoid-induced osteoporosis. J Cell Biochem (2006) 0.86
Differentiated thyroid carcinoma risk factors in French Polynesia. Asian Pac J Cancer Prev (2014) 0.86
Effects of regenerative radioelectric asymmetric conveyer treatment on human normal and osteoarthritic chondrocytes exposed to IL-1β. A biochemical and morphological study. Clin Interv Aging (2013) 0.86
Menstrual and reproductive factors in the risk of differentiated thyroid carcinoma in young women in France: a population-based case-control study. Am J Epidemiol (2014) 0.86
Phase I trial of thymidylate synthase poly-epitope peptide (TSPP) vaccine in advanced cancer patients. Cancer Immunol Immunother (2015) 0.86
Long-term effects of neridronate on human osteoblastic cell cultures. Bone (2004) 0.85
Further insights in the mechanisms of interleukin-1beta stimulation of osteoprotegerin in osteoblast-like cells. J Bone Miner Res (2007) 0.85
Role of radiotherapy and chemotherapy in the risk of secondary leukaemia after a solid tumour in childhood. Eur J Cancer (2006) 0.85
Assessment of specific mRNA levels in cartilage regions in a lapine model of osteoarthritis. J Orthop Res (2002) 0.85
Absolute risk prediction of second primary thyroid cancer among 5-year survivors of childhood cancer. J Clin Oncol (2012) 0.85
Interleukin-6 receptor shedding is enhanced by interleukin-1beta and tumor necrosis factor alpha and is partially mediated by tumor necrosis factor alpha-converting enzyme in osteoblast-like cells. Arthritis Rheum (2005) 0.84
Rheologic behavior of osteoarthritic synovial fluid after addition of hyaluronic acid: a pilot study. Clin Orthop Relat Res (2009) 0.84